OC.10.2 A SERUM METABOLOMICS ANALYSIS TO UNDERSTAND THE INTERPLAY BETWEEN BIOLOGICAL THERAPIES IN IBD PATIENTS AND SUSCEPTIBILITY TO SARS-COV-2 INFECTION

Detalles Bibliográficos
Autores principales: Pisani, L.F., Mola, S., Crespi, G., Caprioli, F., Annunaziata, M., Manfredi, M., Pastorelli, L., Porta, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:
Oral Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065936/
http://dx.doi.org/10.1016/S1590-8658(22)00327-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065936/
http://dx.doi.org/10.1016/S1590-8658(22)00327-9

Ejemplares similares